As of 2025-05-22, the Net Margin of Transgene Biotek Ltd (526139.BO) is -279.1%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-03-31 | -279.1% |
2023-03-31 | -10907.9% |
2022-03-31 | -11998.4% |
2021-03-31 | -6154.3% |
2020-03-31 | -306636% |
2019-03-31 | -12334.2% |
2018-03-31 | -5445.2% |
2017-03-31 | -7071.7% |
2016-03-31 | -11864.4% |
2015-03-31 | -5750.4% |